Baker, EH;
Patel, K;
Ball, J;
Edwards, S;
Harrison, TS;
Kaul, A;
Koh, M;
... Forton, DM; + view all
(2021)
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.
British Journal of Clinical Pharmacology
, 87
(3)
pp. 1584-1586.
10.1111/bcp.14466.
Preview |
Text
Edwards_Insights from compassionate use of tocilizumab for COVID.pdf - Accepted Version Download (435kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/bcp.14466 |
| Publisher version: | https://doi.org/10.1111/bcp.14466 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Science and Technology Studies |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10124296 |
Archive Staff Only
 |
View Item |
